Controversial Alzheimer’s surgery is said to reverse symptoms. Here’s what scientists say
Jaw-dropping patient videos and miraculous testimonials ignited a frenzy in China over a technique that aims to improve drainage from the brain in dementia patients. Now it is entering trials worldwide
Alzheimer’s blood tests predict what age people will be when the disease may cause symptoms, study finds
Tests that could reveal when Alzheimer’s disease will emerge, while promising, are not ready for use in otherwise healthy people, scientists say
GLP-1 Pill Fails to Slow Alzheimer’s Progression in Clinical Trial
Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral semaglutide failed to slow down Alzheimer's progression
Men’s Brains Shrink Faster than Women’s. What That Means for Alzheimer’s
Women’s brains age more slowly than men’s, but they still have higher rates of Alzheimer’s disease
Babies Are Born with High Levels of Alzheimer’s-Linked Proteins in Their Brains
Researchers hope the finding could point to new therapeutic approaches for the disease
New Hope in Alzheimer’s Research: A Special Report
Breakthrough therapies, new diagnostics and preventive measures for fighting a devastating disease
Can we fix America’s dementia care crisis before it’s too late?
More than 13.8 million Americans could have Alzheimer’s by 2060, and at the rate care facilities are closing, many of them will have nowhere to go. Regina Shih of the State Alzheimer’s Research Support Center (StARS) wants to help solve that problem
Alzheimer’s drugs are finally tackling the disease itself. Here’s how
While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 clinical trials, offer new hope
Can diet and exercise really prevent Alzheimer’s?
Early studies suggest that lifestyle changes such as diet, exercise and social engagement may help slow or prevent Alzheimer’s symptoms—but the evidence is inconsistent, and many doctors remain cautious
The vexing promise of new blood tests for Alzheimer’s
A new generation of Alzheimer’s blood tests could speed up diagnosis and access to care—but they also raise thorny questions about prediction, treatment and uncertainty
Controversial new Alzheimer’s drugs offer hope—but at a high cost
New Alzheimer’s drugs known as anti-amyloid therapies may slow disease progression—but they also carry serious risks, including brain bleeds and strokelike symptoms
The Hidden Link between Racism and Alzheimer’s Risk
Black Americans face a significantly higher risk of Alzheimer’s and other dementias than white Americans. Researchers are working to find out why that is and how to intervene